AristaMD
PrivateLast Round
Series C
Nov 14, 2023
Total Funding Raised
$67.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AristaMD operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series C round in November 2023.
AristaMD is a digital health company that provides a platform with eConsults, virtual consultations, and referral management tools to connect primary care providers with specialists.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Vertical SaaS, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AristaMD Comparables
Compare AristaMD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ConferMED | 88% | |
| Safety Net Connect | 83% | |
| PicassoMD | 83% |
For institutional investors. Book with your work email.
AristaMD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 14, 2023 | ||||
| Series B Extension | Mar 30, 2022 | ||||
| Series B | Jul 14, 2020 | ||||
| Series B Extension | Jul 14, 2020 | ||||
| VC Round | Jan 4, 2017 | ||||
Series A | Jul 20, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AristaMD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cobalt Ventures | Series B Extension |
| Ascension Ventures | Series B Extension, Series B |
| Cigna Ventures | Series B Extension, Series B |
| Avalon Ventures | Series B, Series B Extension, Series A |
| 406 Ventures | Series B Extension, Series B |
| Correlation Ventures | Series A |
| Ascension Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- Jun 23, 2026
Monthly visitors grew 123% MoM, reaching 21.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 17, 2026
AristaMD, Inc. appoints Allison Ginsberg as Senior Vice President, People in California on Sep 17th '26, where she leads the People strategy across clinical teams, operations, engineering, and growth.
- has_revenueAug 10, 2026
In Jul '25, AristaMD, Inc. records estimated revenue of $7.4M.
For institutional investors. Book with your work email.
AristaMD Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AristaMD's valuation, stock price, and market status.
Is AristaMD a public or private company?
AristaMD is a private company.
What is the current stock price of AristaMD?
AristaMD is a private company, so its shares have no public market price. Caplight tracks AristaMD's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AristaMD worth (valuation)?
Valuation information for AristaMD is not publicly available.
Can I buy AristaMD stock?
AristaMD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AristaMD's last funding round?
AristaMD's most recent funding round was Series C on November 14, 2023.
Who are the main investors in AristaMD?
Key investors in AristaMD include Cobalt Ventures, Cigna Ventures, Avalon Ventures.
Will AristaMD IPO soon?
No public IPO plans have been announced for AristaMD.
How can I track AristaMD secondary market activity?
Caplight tracks bids, offers, and trades in AristaMD's shares on secondary markets.